Sign In
Get Clay Free →

Suggestions

    Robert Klein

    CEO and Scientist

    Robert Klein is a prominent figure in the health tech sector, excelling in both scientific and commercial realms. With a rich background and extensive global experience, he has showcased his skills in business development, scientific outreach, partnerships, KOL development, pharma collaborations, therapeutic development, and commercialization.

    Robert's educational journey includes a Bachelor's degree in Biochemistry from the University of California, Berkeley, followed by a Ph.D. in Biology from the esteemed Massachusetts Institute of Technology.

    Throughout his career, Robert has held key leadership positions in various organizations, demonstrating his versatility and expertise. He has served as Chief Executive Officer and Founder at Karnateq and Addition Therapeutics, Chief Business Officer at Alkahest, Inc., Consultant, Chief Business Officer at Complete Genomics Inc., CEO and Founder at iKaryos Diagnostics, Inc., CSO at Amnestix, Senior Director of Business Development and Research at Pfizer Global R&D and Rinat Neuroscience, VP of Business Development and Technology Development at Deltagen, as well as a Scientist at Genentech, Inc.

    Robert Klein's domain expertise lies in genomics, population genomics, translational research, and utilizing large-scale genomic data for therapeutic advancements and population health. His impressive track record speaks to his ability to translate scientific endeavors into successful commercial outcomes.

    Robert Klein
    Add to my network

    Location

    Palo Alto, California, United States